You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced unresectable Solid Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Unresectable Solid Tumors Trial in Beijing (M108)

Recruiting
  • Advanced Unresectable Solid Tumors
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jul 25, 2022

Unresectable or Metastatic Advanced Solid Tumors Trial (WTX212A)

Not yet recruiting
  • Unresectable or Metastatic Advanced Solid Tumors
  • (no location specified)
Sep 6, 2023

Solid Tumors Trial (IBR854 Cell Injection)

Not yet recruiting
  • Solid Tumors
  • IBR854 Cell Injection
  • (no location specified)
Aug 14, 2023

Solid Tumor Trial in Sydney (IBI129)

Not yet recruiting
  • Solid Tumor
  • Sydney, New South Wales, Austria
    St George private Hospital
Aug 6, 2023

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Solid Tumors Trial in Waratah (IBI334)

Not yet recruiting
  • Solid Tumors
  • Waratah, New South Wales, Australia
    Westmead Hospital
Mar 7, 2023

Solid Tumor Trial in Zhengzhou, Jinan (RC148)

Not yet recruiting
  • Solid Tumor
  • Zhengzhou, Henan, China
  • +2 more
Aug 24, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

Solid Tumor Trial (TXN10128)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Jul 29, 2023

Solid Tumor Trial in Birtinya (IBI130)

Not yet recruiting
  • Solid Tumor
  • Birtinya, Queensland, Australia
    Sunshine Coast University
Jun 19, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in Randwick, Sunshine Coast, Clayton (IBI354)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • IBI354
  • Randwick, New South Wales, Australia
  • +2 more
Dec 8, 2022

Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I

Not yet recruiting
  • Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
  • Phase I dose escalation
  • +3 more
  • Shanghai, Shanghai, China
    Fudan Cancer Hospital
Apr 24, 2023

Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Trial in Chuo-ku (ASP1948)

Completed
  • Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
  • Chuo-ku, Tokyo, Japan
    Site JP810001
Jan 17, 2023

Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

Not yet recruiting
  • Breast Cancer Metastatic
  • +7 more
  • Denver, Colorado
  • +1 more
Apr 28, 2023

Solid Tumor, Adult Trial in Providence, Nashville (DF6215)

Not yet recruiting
  • Solid Tumor, Adult
  • Providence, Rhode Island
  • +1 more
Oct 25, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in Benowa (IBI343)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • Benowa, Queensland, Australia
    Pindara Private Hospital
Jul 11, 2022

Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

Not yet recruiting
  • Melanoma
  • +5 more
  • RC198 Injection
  • Auchenflower, Queensland, Australia
    Research Site
May 17, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in China (SG1906)

Recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • Beijing, Beijing, China
  • +8 more
May 12, 2023

MSI-H/dMMR Solid Tumor Trial in Guangzhou (AK104)

Terminated
  • MSI-H/dMMR Solid Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 17, 2022

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

RET-altered Solid Tumors Trial in Shanghai (APS03118)

Recruiting
  • RET-altered Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 8, 2022

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

Solid Tumor Trial in Guangzhou (CAN1012)

Recruiting
  • Solid Tumor
  • Guangzhou, Guangdong, China
    Canwell Biotech Limited
Oct 13, 2022

Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

Not yet recruiting
  • Metastatic Solid Tumor
  • TAC01-CLDN18.2
  • (no location specified)
May 8, 2023

Breast Cancer, Solid Tumor Trial in Shanghai (BL-B01D1)

Recruiting
  • Breast Cancer
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Jul 20, 2022